Molecular detection of TP53, Ki-Ras and p16INK4A promoter methylation in plasma of patients with colorectal cancer and its association with prognosis. Results of a 3-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study-Reference-Cited by-同舟云学术

Molecular detection of TP53, Ki-Ras and p16INK4A promoter methylation in plasma of patients with colorectal cancer and its association with prognosis. Results of a 3-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study

Published:2006-06 Issue: Volume:17 Page:vii84-vii90
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Bazan V.,Bruno L.,Augello C.,Agnese V.,Calò V.,Corsale S.,Gargano G.,Terrasi M.,Schirò V.,Di Fede G.,Adamo V.,Intrivici C.,Crosta A.,Rinaldi G.,Latteri F.,Dardanoni G.,Grassi N.,Valerio M.R.,Colucci G.,Macaluso M.,Russo A.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/17/suppl_7/vii84/347763/mdl958.pdf

Reference20 articles.

1. Some recent developments in the epidemiology of colorectal cancer;Boyle,1998

2. Detection of free-circulating tumor-associated DNA in plasma of colorectal cancer patients and its association with prognosis;Lecomte;Int J Cancer,2002

3. Difference between free circulating plasma and serum DNA in patients with colorectal liver metastases;Thijssen;Anticancer Res,2002

4. Detection of cancer cells in the peripheral blood of gastric cancer patients;Ikeguchi;Int J Mol Med,2003

5. Prognostic and predictive factors in colorectal cancer: Kirsten Ras in CRC (RASCAL) and TP53 CRC collaborative studies;Russo;Ann Oncol,2005

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Prognostic Utility of KRAS Mutations in Tissue and Circulating Tumour DNA in Colorectal Cancer Patients;Gastroenterology Insights;2024-01-27

2. Pilot Study of Recurrent Ewing's Sarcoma Management with Vigil/Temozolomide/Irinotecan and Assessment of Circulating Tumor (ct) DNA;Clinical Cancer Research;2023-02-13

3. Predictive and Prognostic Markers for Cancer Medicine;Precision Medicine in Oncology;2020-08-14

4. ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal–Anal Task Forces whitepaper;Nature Reviews Clinical Oncology;2020-07-06

5. Circulating Tumour Cells, Circulating Tumour DNA and Circulating Tumour miRNA in Blood Assays in the Different Steps of Colorectal Cancer Management, a Review of the Evidence in 2019;BioMed Research International;2019-12-16